New players in phototherapy: photopharmacology and bio-integrated optoelectronics

Johannes Morstein, Dirk Trauner

Research output: Contribution to journalReview article

Abstract

Photodynamic therapy and phototherapy are used in the clinic to treat dermatological conditions, cancer, macular degeneration, and a variety of other diseases. Despite their long history and widespread application, the scope of these therapeutic approaches has been limited by a lack of specificity and challenges with light delivery. In recent years, much progress has been made in these regards. Photopharmacology has provided drug-like molecules that change their efficacy upon irradiation and allow for the optical control of a wide range of defined biological targets. Many photopharmaceuticals are now used in vivo and some show promising results in preclinical development. At the same time, new bioelectronics for subdermal light delivery have been engineered that could enable phototherapy deep in tissue, for example within the human brain. These developments could increase the impact of photodynamic therapy in human precision medicine.

Original languageEnglish (US)
Pages (from-to)145-151
Number of pages7
JournalCurrent Opinion in Chemical Biology
Volume50
DOIs
StatePublished - Jun 1 2019

Fingerprint

Integrated optoelectronics
Photodynamic therapy
Phototherapy
Photochemotherapy
Light
Precision Medicine
Macular Degeneration
Medicine
Brain
History
Irradiation
Tissue
Molecules
Pharmaceutical Preparations
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry

Cite this

New players in phototherapy : photopharmacology and bio-integrated optoelectronics. / Morstein, Johannes; Trauner, Dirk.

In: Current Opinion in Chemical Biology, Vol. 50, 01.06.2019, p. 145-151.

Research output: Contribution to journalReview article

@article{0e5fd16efc1b48d8980abc6d8468ebe9,
title = "New players in phototherapy: photopharmacology and bio-integrated optoelectronics",
abstract = "Photodynamic therapy and phototherapy are used in the clinic to treat dermatological conditions, cancer, macular degeneration, and a variety of other diseases. Despite their long history and widespread application, the scope of these therapeutic approaches has been limited by a lack of specificity and challenges with light delivery. In recent years, much progress has been made in these regards. Photopharmacology has provided drug-like molecules that change their efficacy upon irradiation and allow for the optical control of a wide range of defined biological targets. Many photopharmaceuticals are now used in vivo and some show promising results in preclinical development. At the same time, new bioelectronics for subdermal light delivery have been engineered that could enable phototherapy deep in tissue, for example within the human brain. These developments could increase the impact of photodynamic therapy in human precision medicine.",
author = "Johannes Morstein and Dirk Trauner",
year = "2019",
month = "6",
day = "1",
doi = "10.1016/j.cbpa.2019.03.013",
language = "English (US)",
volume = "50",
pages = "145--151",
journal = "Current Opinion in Chemical Biology",
issn = "1367-5931",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - New players in phototherapy

T2 - photopharmacology and bio-integrated optoelectronics

AU - Morstein, Johannes

AU - Trauner, Dirk

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Photodynamic therapy and phototherapy are used in the clinic to treat dermatological conditions, cancer, macular degeneration, and a variety of other diseases. Despite their long history and widespread application, the scope of these therapeutic approaches has been limited by a lack of specificity and challenges with light delivery. In recent years, much progress has been made in these regards. Photopharmacology has provided drug-like molecules that change their efficacy upon irradiation and allow for the optical control of a wide range of defined biological targets. Many photopharmaceuticals are now used in vivo and some show promising results in preclinical development. At the same time, new bioelectronics for subdermal light delivery have been engineered that could enable phototherapy deep in tissue, for example within the human brain. These developments could increase the impact of photodynamic therapy in human precision medicine.

AB - Photodynamic therapy and phototherapy are used in the clinic to treat dermatological conditions, cancer, macular degeneration, and a variety of other diseases. Despite their long history and widespread application, the scope of these therapeutic approaches has been limited by a lack of specificity and challenges with light delivery. In recent years, much progress has been made in these regards. Photopharmacology has provided drug-like molecules that change their efficacy upon irradiation and allow for the optical control of a wide range of defined biological targets. Many photopharmaceuticals are now used in vivo and some show promising results in preclinical development. At the same time, new bioelectronics for subdermal light delivery have been engineered that could enable phototherapy deep in tissue, for example within the human brain. These developments could increase the impact of photodynamic therapy in human precision medicine.

UR - http://www.scopus.com/inward/record.url?scp=85065724947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065724947&partnerID=8YFLogxK

U2 - 10.1016/j.cbpa.2019.03.013

DO - 10.1016/j.cbpa.2019.03.013

M3 - Review article

C2 - 31108317

AN - SCOPUS:85065724947

VL - 50

SP - 145

EP - 151

JO - Current Opinion in Chemical Biology

JF - Current Opinion in Chemical Biology

SN - 1367-5931

ER -